Closed
NHS Framework Agreement for the supply of Ranibizumab for the NHS in England
Request tender documents
Save your time. You just request and we will send you the available documents.
Request for bid service
Save your time. You just request and we will arrange tender related all available documents to bid writers for the best possible quote.
Descriptions
The Procurement relates to the supply of ranibizumab an Anti Veg-F medicine used in medical retinal vascular services for the NHS in England. Anti Veg-F medicines are currently used in the treatment of: a.neovascular (wet) age-related macular degeneration (AMD); b.visual impairment due to diabetic macular oedema (DME/DMO); c.visual impairment due to myopic choroidal neovascularisation (myopic CNV); and d.visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO). Period of framework: 1 April 2023 to 31 March 2024 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 24 months) Framework Reference Number: CMD/SCM/MJP/2023/01 Atamis Reference Number: C123966 http://health.atamis.co.uk/
Timeline
Published Date :
Deadline :
Contract Start :
Contract End :
Tender Regions
CPV Codes
33690000 - Various medicinal products
33600000 - Pharmaceutical products
Keywords
medicinal drugs
prescription medicines
generic pharmaceuticals
active pharmaceutical ingredients
pharmaceutical compounds
diverse pharmaceuticals
general drug products
healthcare medications
assorted therapeutic agents
medical product range
Tender Lot Details
2 Tender Lots
Workflows
Status :
Procedure :
Suitable for SME :
Nationwide :
Assign to :
Tender Progress :
Details
Notice Type :
Tender Identifier :
Tenderbase ID :
Low Value :
High Value :
Buyer Information
Name :
Procurement contact
Name :
Phone :
Email :
Possible Competitors
1 Possible Competitors
